Tributary Capital Management, LLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 299 filers reported holding SEATTLE GENETICS INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
Tributary Capital Management, LLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$1,918,000
-13.8%
9,800
-25.2%
0.17%
-12.6%
Q2 2020$2,226,000
+25.3%
13,100
-14.9%
0.19%
+5.0%
Q1 2020$1,777,000
-2.8%
15,400
-3.8%
0.18%
+41.4%
Q4 2019$1,828,000
+23.8%
16,000
-7.5%
0.13%
+19.6%
Q3 2019$1,477,000
+22.0%
17,300
-1.1%
0.11%
+25.9%
Q2 2019$1,211,000
-10.6%
17,500
-5.4%
0.08%
-13.3%
Q1 2019$1,355,000
+29.3%
18,5000.0%0.10%
+2.1%
Q4 2018$1,048,000
-26.6%
18,5000.0%0.10%
-11.1%
Q3 2018$1,427,000
-11.2%
18,500
-23.6%
0.11%
-14.3%
Q2 2018$1,607,000
+23.8%
24,200
-2.4%
0.13%
+15.6%
Q1 2018$1,298,000
+39.4%
24,800
+42.5%
0.11%
+34.6%
Q4 2017$931,000
-56.3%
17,400
-55.6%
0.08%
-12.0%
Q3 2017$2,132,000
+104.0%
39,200
+94.1%
0.09%0.0%
Q2 2017$1,045,000
-42.0%
20,200
-29.6%
0.09%
-47.7%
Q1 2017$1,803,000
-28.5%
28,690
-40.0%
0.18%
-40.5%
Q4 2016$2,522,000
-7.9%
47,800
-5.7%
0.30%
-16.9%
Q3 2016$2,738,000
+33.6%
50,7000.0%0.36%
+19.1%
Q2 2016$2,049,000
+8.8%
50,700
-5.6%
0.30%
+0.7%
Q1 2016$1,884,000
-16.5%
53,700
+6.8%
0.30%
-20.4%
Q4 2015$2,257,000
+10.9%
50,300
-4.7%
0.37%
+10.0%
Q3 2015$2,036,000
-10.9%
52,800
+11.9%
0.34%
-4.8%
Q2 2015$2,284,00047,2000.36%
Other shareholders
SEATTLE GENETICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Baker Brothers Advisors 50,060,240$5,775,950,00035.57%
Lagoda Investment Management, L.P. 72,969$8,419,0009.97%
Avidity Partners Management LP 580,000$66,920,0009.25%
Arabesque Asset Management Ltd 14,807$1,708,0003.53%
Boxer Capital, LLC 400,000$46,152,0003.15%
Woodline Partners LP 364,333$42,037,0003.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 56,900$6,557,0002.99%
SECTORAL ASSET MANAGEMENT INC 107,000$12,346,0002.37%
Capital International, Inc./CA/ 1,197,659$138,186,0002.33%
Bain Capital Public Equity Management II, LLC 169,641$19,573,0002.29%
View complete list of SEATTLE GENETICS INC shareholders